Exercise before and during chemotherapy may boost treatment success

NCT ID NCT07502963

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a supervised exercise program, started two weeks before chemotherapy and continued for 16 weeks during treatment, can help adults aged 35 to 65 with breast, lung, or colon cancer tolerate chemotherapy better. The goal is to see if participants can receive more than 85% of their planned chemotherapy dose and achieve a higher rate of complete tumor disappearance. Seventy participants will be randomly assigned to either the exercise program or usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
supervised exercise program
What this could lead to
If it works, this could show that a structured exercise program helps patients complete more of their chemotherapy and potentially improve treatment response.
What could go wrong
This is a small, early-stage trial with only 70 participants, so results may not apply to everyone. Exercise may not significantly improve chemotherapy tolerance or outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Consorci Hospitalari de Vic

    Vic, Barcelona, 08500, Spain

  • Facultat de Ciències de la Salut i del Benestar de la Universitat de Vic (UVIC-UCC) Universitat de Vic- Universitat Central de Catalunya

    Vic, Barcelona, 08500, Spain

  • Hospital Universitari de la Santa Creu

    Vic, Barcelona, 08500, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.